Table 6.
Resistance patterns of gram negative bacterial isolates to main antimicrobial agents.
| Isolates | Number of isolates resistant/number of isolates tested (%) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chloramphenicol | Gentamicin | Ceftriaxone | Ciprofloxacin | TPM/SMX | Ceftazidime | AMC/CLV | Meropenem | Colistin | |
| Proteus spp. | 15/67 (22.4) | 21/66 (31.8) | 37/63 (58.7) | 13/67 (19.4) | 56/65 (86.2) | 34/60 (56.7) | 48/70 (68.6) | 0/15 (0.0) | 0/24 (0.0) |
| P. aeruginosa | 7/16 (43.8) | 10/54 (18.5) | N | 19/75 (25.3) | N | 2/21 (9.5) | N | 0/6 (0.0) | 0/25 (0.0) |
| K. pneumonia | 11/56 (19.6) | 21/63 (33.3) | 46/65 (70.8) | 10/60 (16.8) | 58/63 (92.1) | 19/34 (55.9) | 48/64 (75.0) | 0/9 (0.0) | 0/8 (0.0) |
| E. coli | 23/110 (20.9) | 58/203 (28.6) | 156/207 (75.4) | 43/198 (21.7) | 81/86 (94.2) | 35/61 (57.3) | 161/202 (79.7) | 0/21 (0.0) | 0/50 (0.0) |
| C. freundii | N | 1/1 (100.0) | N | N | 0/1 (0.0) | 1/1 (100.0) | 0/1 (0.0) | ||
N- Not tested, TPM/SMX- Trimethoprim-Sulphamethoxazole, AMC/CLV- Amoxycillin-Clavulanic Acid.